ロード中...
Immunotherapy for metastatic renal cell carcinoma
BACKGROUND: Since the mid‐2000s, the field of metastatic renal cell carcinoma (mRCC) has experienced a paradigm shift from non‐specific therapy with broad‐acting cytokines to specific regimens, which directly target the cancer, the tumour microenvironment, or both. Current guidelines recommend targe...
保存先:
| 出版年: | Cochrane Database Syst Rev |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley & Sons, Ltd
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6484451/ https://ncbi.nlm.nih.gov/pubmed/28504837 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD011673.pub2 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|